Marker

    Immunostaining     intensity

No. of +ve. cases

No. of cases with mild (weak) staining intensity

No. of cases with moderate staining intensity

 

 No. of cases with strong staining intensity

 
PAHS exposed uninvolved skin (n=113)

P53

101

7

88

6

Bcl-2

3

3

0

0

Bax

107

6

38

63

SCC cases (n=9)

P53

9

0

7

2

Bax

8

1

6

1

Bcl-2

0

0

0

0

Table 2: Immunostaining intensity of P53, Bax and Bcl-2 in uninvolved skin and SCC cases of PAHs exposed group.